Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements
Else Marie Agger, Ida Rosenkrands, Jon Hansen et al. · 2008
Read Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements by Else Marie Agger, Ida Rosenkrands, Jon Hansen et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003116.txt.
Description
Else Marie Agger, Ida Rosenkrands, Jon Hansen and co-authors tested a liposome adjuvant called CAF01 in 2008. For vaccines against influenza, malaria, and HIV, antibody responses alone are not enough; a strong cell-based response is also needed for enough protection. Some diseases need still other response types, so one adjuvant rarely fits all.
CAF01 pairs cationic liposomes with a synthetic form of mycobacterial cord factor. The team presents it as a versatile adjuvant for vaccines with different immune needs. Published in PLOS ONE, such range in an adjuvant would make vaccine design simpler across diseases. Readers can follow the full methods and data in the complete text of the article.
Catalog record
| CREATOR | Else Marie Agger, Ida Rosenkrands, Jon Hansen et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003116